Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07485335 · ClinicalTrials.gov registry record · Phase 4
A Bundled Intervention to End Opioid Overdoses
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT07485335 is a Phase 4 study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 160 participants.
The verdict
NCT07485335, a Phase 4 study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
Opioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patient population. A bundled intervention is proposed, including telehealth, peer support specialist, buprenorphine, and linkage for definitive care, that is designed to increase treatment uptake in this patient population post-ED discharge, reduce repeat opioid overdoses, and end overdose deaths.
Interventions
- OTHER control group
- OTHER Bundled intervention (Experimental)
- DRUG Buprenorphine (Experimental)
- BEHAVIORAL Scheduled Peer Support Specialist (Experimental)
- OTHER Telemedicine Buprenorphine Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-09-07 |
| Est. Completion | 2030-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07485335
The ClinicalTrials.gov registry entry for NCT07485335 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which control group is the first listed.
NCT07485335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07485335 about?
NCT07485335 is a clinical study titled "A Bundled Intervention to End Opioid Overdoses". Opioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patient population. A bun...
What is the current status of trial NCT07485335?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2026-09-07. Estimated completion is 2030-09-30.
What interventions are being tested in trial NCT07485335?
The interventions under investigation include: control group (OTHER), Bundled intervention (Experimental) (OTHER), Buprenorphine (Experimental) (DRUG), Scheduled Peer Support Specialist (Experimental) (BEHAVIORAL), Telemedicine Buprenorphine Treatment (OTHER).
Who is sponsoring clinical trial NCT07485335?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.